SUBSCRIBE

CATEGORIES

Orbimed Advisors increased stake in Edgewise Therapeutics, Inc.

imageStock Markets20 minutes ago (May 04, 2021 04:30AM ET)

(C) Reuters. Orbimed Advisors increased stake in Edgewise Therapeutics, Inc.

On the 30th of March, Orbimed Advisors bought 359 thousand Edgewise Therapeutics, Inc. (EWTX) shares for $5.8 million at an average price of $16.00 per share.
Shares of Edgewise Therapeutics, Inc. are down -7.27% since the transaction.

Orbimed Advisors’s holding in Edgewise Therapeutics, Inc. increased to about 13 million shares with the purchase.

Orbimed Advisors increased stake in Edgewise Therapeutics, Inc.

Mediaset shares rally after peace deal with Vivendi

Mediaset shares rally after peace deal with Vivendi
By Reuters – May 04, 2021

By Elvira Pollina MILAN (Reuters) -Mediaset rallied on Tuesday after it agreed a consensual break-up with its second-largest investor Vivendi (OTC:VIVHY) , putting an end to years…

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

image

Our Apps

DOWNLOAD APPApp store

Investing.com

(C) 2007-2021 Fusion Media Limited. All Rights Reserved

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.